Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Connie Anderson

Physician Assistant Holland, MI Physician Assistant

NPI 1124012919 CMS profile 11005754

3290 N Wellness Dr Ste 240, Holland, MI 49424

Open in the dashboard

General payments

$6,108

275 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Connie Anderson of Holland, MI is reported in the CMS Open Payments database as having received $6,108 across 275 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,788 81
2024 General $1,300 56
2023 General $1,080 47
2022 General $1,071 50
2021 General $870 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Connie Anderson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Connie Anderson were reported at $1,788. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Connie Anderson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $870 $132 $37–$438 $132
2022 $1,071 $155 $48–$522 $149
2023 $1,080 $167 $52–$557 $160
2024 $1,300 $178 $55–$600 $164
2025 $1,788 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $1,289 63 payments
  2. Sun Pharmaceutical Industries Inc. $608 25 payments
  3. Regeneron Healthcare Solutions, Inc. $461 21 payments
  4. AbbVie, Inc. $444 22 payments
  5. Janssen Biotech, Inc. $430 13 payments
  6. Pfizer Inc. $401 19 payments
  7. Amgen Inc. $378 18 payments
  8. Genzyme Corporation $331 10 payments
  9. UCB, Inc. $316 14 payments
  10. E.R. Squibb & Sons, L.L.C. $300 13 payments
  11. Other $1,152 57 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,829 272 payments
  2. Education $279 3 payments
Products named General payments · program years 2021–2025
  1. COSENTYX Dermatology $682 28 payments
  2. DUPIXENT Immunology $409 13 payments
  3. TREMFYA $407 12 payments
  4. Otezla $378 18 payments
  5. COSENTYX Immunology $368 21 payments
  6. EUCRISA $340 17 payments
  7. ILUMYA $315 15 payments
  8. CIBINQO $304 14 payments
  9. SOTYKTU $300 13 payments
  10. DUPIXENT Inflammation And Immunology $292 11 payments
  11. Other $3,108 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

331

Median for Physician Assistant: 241

Drug cost

$10,681

Median for Physician Assistant: $4,110

Branded share of claims

8.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluorouracil Generic 55 $3,225
Tretinoin Generic 16 $1,470
Metronidazole Generic 21 $1,209
Clobetasol Propionate Generic 41 $820
Betamethasone Dipropionate Generic 11 $652
Fluocinonide Generic 12 $629
Methotrexate Methotrexate Sodium Brand 27 $601
Doxycycline Hyclate Generic 26 $577
Triamcinolone Acetonide Generic 49 $451
Ketoconazole Generic 25 $442

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$26,611

Medicare's payments for the services billed

Medicare patients

196

Average age 76

Services billed

871

93 women, 103 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 39%
Ischemic heart disease 21%
Diabetes 19%
Chronic kidney disease 18%
Cancer 17%
Atrial fibrillation 16%
Depression 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $169
  • GENZYME CORPORATION $72
$242 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $198
$198 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $177
$177 — —
ILUMYA
  • Sun Pharmaceutical Industries Inc. $121
$121 — —
OPZELURA
  • Incyte Corporation $93
$93 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

275 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record